Expansion of CD5- B cells in multiple sclerosis correlates with CD80 (B7-1) expression

The pathogenetic role of autoantibodies in multiple sclerosis (MS) is uncertain. CD5(+) B cells commonly produce autoantibodies, but CD5 expression has also been implicated in B-cell tolerance. We studied B-cell subsets, anti-myelin protein antibody-secreting cells in cerebrospinal fluid (CSF) and a panel of serum autoantibodies in patients with clinically isolated syndromes (CIS), suggestive of MS and patients with clinically definite MS (CDMS). Patients with CDMS had a higher percentage of CD5(-) B cells in CSF than did control subjects (P = 0.02). CIS patients with immunoglobulin G (IgG) oligoclonal bands in CSF or multiple lesions on magnetic resonance imaging (MRI) had a higher percentage of CD5(-) B cells in CSF than did the remaining CIS patients (P = 0.03). The percentage of CD5(-) and CD80(+) B cells correlated positively and the percentage of CD5(+) B cells correlated negatively with the number of CSF cells secreting anti-myelin basic protein (anti-MBP) antibodies. The prevalence of serum autoantibodies was comparable in the three patient groups. We conclude that intrathecal expansion of CD5(-) B cells appears to be more characteristic in MS patients, and CD5(+) B cells may be associated with a lower prevalence of anti-myelin antibody production.